← Back to Search

Microcurrent for Fibromyalgia

N/A
Recruiting
Research Sponsored by Paul Crawford
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Symptom duration of at least 3 months
Tender points: having >10/18 tender points
Must not have
Peripheral neuropathy
Subjects scheduled for surgery will not be eligible to participate in this study until 6 weeks post-surgery
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 15

Summary

This trial will explore the use of microcurrent therapy for fibromyalgia patients and evaluate its effect on generalized pain and quality of life. The goal is to determine if microcurrent therapy can be self-administered by the patient as an adjunct to medical pain management.

Who is the study for?
This trial is for Active Duty or DoD beneficiaries aged 18-74 with fibromyalgia, experiencing widespread pain for at least 3 months and having more than 10 tender points. Participants must have had a neck injury in the past and be able to receive care at Nellis Air Force Base.
What is being tested?
The study tests if microcurrent therapy using a Transcutaneous Electrical Nerve Stimulator (TENS) can reduce generalized pain and improve life quality in fibromyalgia patients compared to a placebo device.
What are the potential side effects?
Microcurrent TENS may cause mild skin irritation where the electrodes are placed. There's also a small risk of discomfort or increased pain due to electrical stimulation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My symptoms have lasted for at least 3 months.
Select...
I have more than 10 tender points on my body.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have nerve damage in my hands or feet.
Select...
I have not had surgery in the last 6 weeks.
Select...
I have had surgery on my brain or spine.
Select...
I have had surgery for trapped nerves.
Select...
My cancer is currently active.
Select...
I have received an organ transplant.
Select...
I have severe bone deformities or stiff joints.
Select...
I do not have any active infections.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 15
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 15 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Measure Yourself Medical Outcome Profile (MYMOP)
Revised Fibromyalgia Impact Questionnaire (FIQR)
active range of motion (AROM)

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: MicrocurrentExperimental Treatment1 Intervention
Group II: PlaceboPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Paul CrawfordLead Sponsor
5 Previous Clinical Trials
917 Total Patients Enrolled

Media Library

Microcurrent Transcutaneous Electrical Nerve Stimulator (TENS) for pain relief Clinical Trial Eligibility Overview. Trial Name: NCT04949100 — N/A
Fibromyalgia Research Study Groups: Placebo, Microcurrent
Fibromyalgia Clinical Trial 2023: Microcurrent Transcutaneous Electrical Nerve Stimulator (TENS) for pain relief Highlights & Side Effects. Trial Name: NCT04949100 — N/A
Microcurrent Transcutaneous Electrical Nerve Stimulator (TENS) for pain relief 2023 Treatment Timeline for Medical Study. Trial Name: NCT04949100 — N/A
Fibromyalgia Patient Testimony for trial: Trial Name: NCT04949100 — N/A
~12 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top